talking biotech

Talking Biotech: Regulating gene-edited animals as drugs will stifle food innovation

, | January 28, 2019
Kevin Folta: University of Florida plant geneticist Kevin Folta launched Talking Biotech in 2015.    More details

New gene-editing techniques have made it possible to introduce rapid, precise genetic changes into the DNA of animals.  Some of the greatest benefits made possible by this innovation include disease resistance, waste reduction, and more rapid animal growth, all of which make food production less costly and more sustainable.

Some countries have adopted these new techniques and devised sensible regulatory oversight to guide their development. However, in the USA, regulation of genetically-engineered animals remains cumbersome, preventing solutions from reaching farmers. In short, a GE animal is regulated as a pharmaceutical drug, whereas a GE plant is regulated as a plant.

Dr. Alison Van Eenennaam sets out to correct this discrepancy.  She points out the problems with burdensome regulation that will affect American scientists and ultimately the American farmer, rancher and consumer. As a solution, she requests that you sign the petition below to help bolster her efforts to support rigorous, thorough, yet reasonable regulation.

Related article:  Will Africa embrace CRISPR gene editing and the next phase of the biotech revolution?

Dr. Van Eenennaam on Twitter: @BioBeef


Sign the petition.

Like the podcast?  Please subscribe and write a review! Subscribe:

Apple Podcasts | Android | Email | Google Podcasts | Stitcher | RSS | Player FM | Pod Directory | TuneIn

GLP Podcast Hosts

Listen to more episodes

News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend